Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) Study
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Rebleeding is associated with mortality in patients with peptic ulcer bleeding (PUB), and risk stratification is important for the management of these patients. The purpose of our study was to examine the risk factors associated with rebleeding in patients with PUB. Methods: The Korean Peptic Ulcer Bleeding registry is a large prospectively collected database of patients with PUB who were hospitalized between 2014 and 2015 at 28 medical centers in Korea. We examined the basic characteristics and clinical outcomes of patients in this registry. Univariate and multivariate analyses were performed to identify the factors associated with rebleeding. Results: In total, 904 patients with PUB were registered, and 897 patients were analyzed. Rebleeding occurred in 7.1% of the patients (64), and the 30-day mortality was 1.0% (nine patients). According to the multivariate analysis, the risk factors for rebleeding were the presence of co-morbidities, use of multiple drugs, albumin levels, and hematemesis/hematochezia as initial presentations. Conclusions: The presence of co-morbidities, use of multiple drugs, albumin levels, and initial presentations with hematemesis/hematochezia can be indicators of rebleeding in patients with PUB. The wide use of proton pump inhibitors and prompt endoscopic interventions may explain the low incidence of rebleeding and low mortality rates in Korea.
Abstract
Background/Aims: Rebleeding is associated with mortality in patients with peptic ulcer bleeding (PUB), and risk stratification is important for the management of these patients. The purpose of our study was to examine the risk factors associated with rebleeding in patients with PUB. Methods: The Korean Peptic Ulcer Bleeding registry is a large prospectively collected database of patients with PUB who were hospitalized between 2014 and 2015 at 28 medical centers in Korea. We examined the basic characteristics and clinical outcomes of patients in this registry. Univariate and multivariate analyses were performed to identify the factors associated with rebleeding. Results: In total, 904 patients with PUB were registered, and 897 patients were analyzed. Rebleeding occurred in 7.1% of the patients (64), and the 30-day mortality was 1.0% (nine patients). According to the multivariate analysis, the risk factors for rebleeding were the presence of co-morbidities, use of multiple drugs, albumin levels, and hematemesis/hematochezia as initial presentations. Conclusions: The presence of co-morbidities, use of multiple drugs, albumin levels, and initial presentations with hematemesis/hematochezia can be indicators of rebleeding in patients with PUB. The wide use of proton pump inhibitors and prompt endoscopic interventions may explain the low incidence of rebleeding and low mortality rates in Korea.
참고문헌 (29)
- Barkun AN, "International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding", Ann Intern Med, 152, pp.101~113 (2010)[DOI]
- Eisner F, "Gastric ulcer complications after the introduction of proton pump inhibitors into clinical routine: 20-year experience", Visc Med, 33, pp.221~226 (2017)[DOI]
- van Leerdam ME, "Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993", 1994 and 2000, 2003, pp.98, 1494~1499
- Barkun A, "The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting", Am J Gastroenterol, 99, pp.1238~1246 (2004)[DOI]
- Silverstein FE, "The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors", Gastrointest Endosc, 27, pp.80~93 (1981)[DOI]
- Marmo R, "Predicting mortality in nonvariceal upper gastrointestinal bleeders: validation of the Italian PNED score and prospective comparison with the Rockall score", Am J Gastroenterol, 105, pp.1284~1291 (2010)[DOI]
- Chiu PW, "Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy", Clin Gastroenterol Hepatol, 7, pp.311~316 (2009)[DOI]
- Spiegel BM, "Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies", Am J Gastroenterol, 98, pp.86~97 (2003)[DOI]
- Brullet E, "A randomized study of the safety of outpatient care for patients with bleeding peptic ulcer treated by endoscopic injection", Gastrointest Endosc, 60, pp.15~21 (2004)[DOI]
- Rockall TA, "Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage", Lancet, 347, pp.1138~1140 (1996)[DOI]
- Saeed ZA, "A scoring system to predict rebleeding after endoscopic therapy of nonvariceal upper gastrointestinal hemorrhage, with a comparison of heat probe and ethanol injection", Am J Gastroenterol, 88, pp.1842~1849 (1993)
- Blatchford O, "A risk score to predict need for treatment for upper-gastrointestinal haemorrhage", Lancet, 356, pp.1318~1321 (2000)[DOI]
- Hay JA, "Upper gastrointestinal hemorrhage clinical--guideline determining the optimal hospital length of stay", Am J Med, 100, pp.313~322 (1996)[DOI]
- Laine L, "Management of patients with ulcer bleeding", Am J Gastroenterol, 107, pp.345~360 (2012)[DOI]
- Owens WD, "ASA physical status classifications: a study of consistency of ratings", Anesthesiology, 49, pp.239~243 (1978)[DOI]
- Forrest JA, "Endoscopy in gastrointestinal bleeding", Lancet, 2, pp.394~397 (1974)
- Barkun A, "Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding", Ann Intern Med, 139, pp.843~857 (2003)[DOI]
- Garcia-Iglesias P, "Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer", Aliment Pharmacol Ther, 34, pp.888~900 (2011)[DOI]
- Sung JJ, "Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding", Gut, 60, pp.1170~1177 (2011)[DOI]
- Liang PS, "A national survey on the initial management of upper gastrointestinal bleeding", J Clin Gastroenterol, 48, pp.e93~e98 (2014)
- Kumar NL, "Association between an increase in blood urea nitrogen at 24 hours and worse outcomes in acute nonvariceal upper GI bleeding", Gastrointest Endosc, 86, pp.1022~1027 (2017)[DOI]
- Gralnek IM, "Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline", Endoscopy, 47, pp.a1~a46 (2015)[DOI]
- Ahmed A, "Upper gastrointestinal bleeding in Scotland 2000- 2010: improved outcomes but a significant weekend effect", World J Gastroenterol, 21, pp.10890~10897 (2015)[DOI]
- de Carvalho Pedroto IM, "Out-of-hours endoscopy for non-variceal upper gastrointestinal bleeding", Scand J Gastroenterol, 50, pp.495~502 (2015)
- Quan S, "Upper-gastrointestinal bleeding secondary to peptic ulcer disease: incidence and outcomes", World J Gastroenterol, 20, pp.17568~17577 (2014)[DOI]
- Malmi H, "Outcomes of patients hospitalized with peptic ulcer disease diagnosed in acute upper endoscopy", Eur J Gastroenterol Hepatol, 29, pp.1251~1257 (2017)[DOI]
- Lin HJ, "A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy", Arch Intern Med, 158, pp.54~58 (1998)[DOI]
- Lau JY, "Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers", N Engl J Med, 343, pp.310~316 (2000)[DOI]
- Leontiadis GI, "Sysntematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia. A post hoc analysis from the Cochrane Collaboration", Aliment Pharmacol Ther, 21, pp.1055~1061 (2005)[DOI]